Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Fintepla for seizures in Dravet syndrome

June 26, 2020

FDA approves Keytruda for recurrent or metastatic cutaneous squamous cell carcinoma

June 25, 2020

FDA grants accelerated approval to Xpovio for relapsed or refractory DLBCL

June 23, 2020

Favipiravir approved in India for mild to moderate COVID-19

June 22, 2020

FDA grants accelerated approval to Tazverik for relapsed/refractory follicular lymphoma

June 19, 2020

FDA approves Crysvita for tumor-induced osteomalacia

June 19, 2020

FDA grants accelerated approval to Zepzelca for metastatic SCLC

June 16, 2020

FDA approves Gardasil 9 for HPV-related oropharyngeal and head and neck cancers

June 15, 2020

FDA approves dispersible tablet formulation of dolutegravir for infants and children with HIV

June 15, 2020

FDA approves Uplizna to treat neuromyelitis optica spectrum disorder

June 12, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...